Summit Therapeutics (MEX:SMMT) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Summit Therapeutics Price-to-Operating-Cash-Flow?

As of today (2025-06-03), Summit Therapeutics's share price is MXN425.32. Summit Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-4.75. Hence, Summit Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Summit Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Summit Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 59.34. The lowest was 20.95. And the median was 45.86.

MEX:SMMT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Summit Therapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2025 was MXN-1.70. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-4.75.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 39.80% per year.

During the past 13 years, Summit Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.60% per year. The lowest was -325.60% per year. And the median was -0.05% per year.

Summit Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Summit Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Summit Therapeutics Price-to-Operating-Cash-Flow Chart

Summit Therapeutics Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Summit Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Summit Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Summit Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Summit Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Summit Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Summit Therapeutics's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Summit Therapeutics Price-to-Operating-Cash-Flow Calculation

Summit Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	425.32	/	-4.746
	=

Summit Therapeutics's Share Price of today is MXN425.32.
Summit Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-4.75.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Summit Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Summit Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Summit Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Summit Therapeutics Inc (MEX:SMMT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

SMMT:USA

Address

601 Brickell Key Drive, Suite 1000, Miami, FL, USA, 33131

Website

https://www.smmttx.com

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.